Related Experiment Video
Updated: Oct 16, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
[Chronopharmacologic approach to the administration of anticancer agents in pancreatic adenocarcinoma. Pilot
C Focan1, F Kreutz, D Focan-Henrard
1Service d'Oncologie médicale, Les Cliniques Saint-Joseph, Liège.
Revue Medicale De Liege
|May 24, 2000
Abstract:
The authors first analyzed the potential interest of the delivery of anticancer agents according to chronobiological concepts for human pancreatic cancer. They report their experience on 41 patients treated in adjuvant (12 cases) or palliative (29 cases) situations. The excellent therapeutic index observed warrants further evaluations of this concept in randomized trials.
